We are monitoring the impact of COVID-19 on MEA Acute Ischemic Stroke Diagnosis & Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 238
Share on
Share on

Middle East & Africa Acute Ischemic Stroke Diagnosis & Treatment Market Analysis - By Diagnostic Type, Surgery Type & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 238
Pages: 145

MEA Acute Ischemic Stroke Treatment & Diagnosis Market Size (2021 to 2026)

The size of the Acute Ischemic Stroke Treatment & Diagnosis Market in the Middle East & Africa was valued at USD 328.59 million in 2021 and estimated to be growing at a CAGR of 6.69%, to reach USD 454.23 million by 2026.

The rising prevalence of acute ischemic stroke is driving the acute ischemic stroke treatment and diagnostics market for diagnostic and surgical treatments in the Middle East and Africa. Also, the acute ischemic stroke diagnosis and treatment market is further estimated to be growing due to an increase in surgical procedures in treating stroke, cerebral ischemic cases, and rising healthcare spending.

In addition, the advanced technology used in surgeries and the growing demand for minimally persistent procedures are the key factors expected to fuel the market growth. Furthermore, the aging population, the increased need for minimally invasive surgery, and rising medical expenditures propel the acute ischemic stroke diagnostic and treatment market forward.

The growing population is significantly influencing the market growth, is the expanding geriatric population in both established and emerging countries, as older individuals are more susceptible to stroke than the younger population. On the other hand, rising tobacco consumption and diabetes prevalence in an aging population are influenced by the market. Furthermore, the acute ischemic stroke diagnostic and treatment market is projected to develop significantly due to growing awareness of stroke and accessible treatment choices, favorable government efforts, and rapid technological advances.

Excessive usage of drugs for the treatment of ischemic stroke and the high cost of surgical procedures are two factors limiting the market growth. In addition, the numerous concerns connected with product development and production may hamper the market’s growth for acute ischemic stroke diagnostics and treatment. In some developing countries, a lack of sufficient awareness is a barrier to market expansion.

This research report on the MEA Acute Ischemic Stroke Treatment & Diagnosis Market has been segmented and sub-segmented into the following categories:

By Diagnostic Type:

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Cerebral Angiography
  • Nuclear Imaging

By Surgery Type:

  • Carotid Endarterectomy
  • Angioplasty
  • Endovascular Mechanical Thrombectomy

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the Middle East and Africa are projected to record a moderate share in the global acute ischemic stroke diagnosis and treatment market during the forecast period. The demand for both diagnostic and surgical treatments in acute stroke is being driven by the increased prevalence of acute ischemic stroke patients, technological developments in surgical techniques, and an aging population.

Key market players in the region are showing a greater focus on health research and development, which is expected to provide lucrative growth opportunities to the market growth. The Middle East is the largest market within this area, accounting for a substantial share due to considered disposable income. However, Africa is anticipated to be the fastest-growing area due to its large population and rising incidence of different cardiovascular diseases such as ischemic stroke.

Africa held the largest share of the MEA acute ischemic stroke diagnosis and treatment market in 2020. Increasing research and development activities, improving the healthcare sector, and supportive government policies are propelling the market growth.

Furthermore, the market in Saudi Arabia is predicted to be expanding during the forecast period, and it is the world’s largest market for stroke diagnosis and treatment. On the other hand, Egypt is predicted to develop at a stable rate over the forecast period in the Middle East and Africa markets. The market in the rest of the Middle East and Africa is expected to grow slowly but steadily. The expansion of the acute stroke diagnosis and treatment market in the Middle East and Africa is driven by significant investments in research and development and numerous government initiatives.


A few of the prominent companies operating in the MEA Acute Ischemic Stroke Diagnosis & Treatment Market profiled in this report are Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Diagnostic Type                                                        

                                5.1.1 Computed Tomography                                    

                                5.1.2 Magnetic Resonance Imaging                                         

                                5.1.3 Ultrasound                                              

                                5.1.4 Cerebral angiography                                         

                                5.1.5 Nuclear Imaging                                    

                5.2 Surgery Type                                                             

                                5.2.1 Carotid Endarterectomy                                    

                                5.2.2 Angioplasty                                             

                                5.2.3 Endovascular Mechanical Thrombectomy                                 

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Abbott Laboratories                                                               

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Covidien plc                                                

                8.3 Johnson & Johnson                                                 

                8.4 Penumbra, Inc.                                                         

                8.5 Philips Healthcare                                                    

                8.6 GE Healthcare                                                           

                8.7 Hitachi, Ltd.                                                

                8.8 Siemens Healthcare                                                

                8.9 Stryker Corporation                                                

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 


                a) List of Tables                                                

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Acute Ischemic Stroke Diagnosis Market By Region, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Computed Tomography Market By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Magnetic Resonance Imaging Market By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Ultrasound Market By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Cerebral angiography Market By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Nuclear Imaging Market By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Carotid Endarterectomy Market By Region, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Angioplasty Market By Region, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Endovascular Mechanical Thrombectomy Market By Region, From 2021 to 2026 (USD Million)
  12. Middle East Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2021 to 2026 (USD Million)
  13. Middle East Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2021 to 2026 (USD Million)
  14. Africa Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2021 to 2026 (USD Million)
  15. Africa Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample